Inhibiting BMAA from Access to Decrease the Risk of Having Neurodegenerative Diseases
DOI:
https://doi.org/10.61173/6fxrv382Keywords:
BMAA, algae, PP2A, Tau protein, Western-blot therapyAbstract
Purpose: Neurodegenerative diseases are commonly seen in groups that have greater age. Although the exact pathway of Alzheimer’s is still unclear, the amino acid BMAA that Nostoc algae have fixed was predicted to inhibit PP2A proteins and cause Hyperphosphorylation on tau proteins and lead to tau protein tangle, which is the known agent that causes Alzheimer’s. So, the paper is dedicated to inhibiting BMAA from inhibiting PP2A kinases and seeing whether it can control the rate of neurodegenerative diseases’ appearance.
References
[1] Arif, M., Kazim, S. F., Grundke-Iqbal, I., Garruto, R. M., & Iqbal, K. (2014). Tau pathology involves protein phosphatase 2A in Parkinsonism-dementia of Guam. Proceedings of the National Academy of Sciences, 111(3), 1144–1149. https://doi. org/10.1073/pnas.1322614111
[2] BILLINGSLEY, M. L., & KINCAID, R. L. (1997). Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking, and neurodegeneration. Biochemical Journal, 323(3), 577–591. https://doi.org/10.1042/bj3230577
[3] Collins, C. A., & Vallee, R. B. (1987). Temperaturedependent reversible assembly of taxol-treated microtubules. Journal of Cell Biology, 105(6), 2847–2854. https://doi. org/10.1083/jcb.105.6.2847
[4] Delcourt, N., Claudepierre, T., Maignien, T., Arnich, N., & Mattei, C. (2017). Cellular and Molecular Aspects of the β-N- Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy. Toxins, 10(1), 6. https://doi.org/10.3390/toxins10010006
[5] Doblin, M., Blackburn, S., & Hallegraeff, G. (1999). Comparative study of selenium requirements of three phytoplankton species: Gymnodinium catenatum, Alexandrium minutum (Dinophyta) and Chaetoceros cf. tenuissimus (Bacillariophyta). Journal of Plankton Research, 21(6), 1153– 1169. https://doi.org/10.1093/plankt/21.6.1153
[6] Flaherty, D. B., Soria, J. P., Tomasiewicz, H. G., & Wood, J. G. (2000). Phosphorylation of human tau protein by microtubuleassociated kinases: GSK3? and cdk5 are key participants. Journal of Neuroscience Research, 62(3), 463–472. https://doi. org/3.0.co;2-7”>10.1002/1097-4547(20001101)62:3<463::aidjnr16>3.0.co;2-7
[7] Hirano, S. (2012). Western Blot Analysis. Methods in Molecular Biology, 87–97. https://doi.org/10.1007/978-1-62703- 002-1_6
[8] Lage, S., Costa, P. R., Moita, T., Eriksson, J., Rasmussen, U., & Rydberg, S. J. (2014). BMAA in shellfish from two Portuguese transitional water bodies suggests the marine dinoflagellate Gymnodinium catenatum as a potential BMAA source. Aquatic Toxicology, 152, 131–138. https://doi. org/10.1016/j.aquatox.2014.03.029
[9] Lu, Q., Kanumury, R., & Wood, J. G. (1994). Abnormal phosphorylation of tau proteins associated with bovine brain microtubules: Activation by excess ATP and tyrosine dephosphorylation. Journal of Neuroscience Research, 37(6), 759–768. https://doi.org/10.1002/jnr.490370610
[10] Lu, Q., & Wood, J. (1993). Functional studies of Alzheimer’s disease tau protein. The Journal of Neuroscience, 13(2), 508–515. https://doi.org/10.1523/ jneurosci.13-02-00508.1993
[11] Pablo, J., Banack, S. A., Cox, P. A., Johnson, T. E., Papapetropoulos, S., Bradley, W. G., Buck, A., & Mash, D. C. (2009). Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease. Acta Neurologica Scandinavica, 120(4), 216–225. https://doi.org/10.1111/j.1600-0404.2008.01150.x
[12] Peng, Q., Li, H., Deng, Q., Liang, L., Wang, F., Lin, Y., Dean&Francis Yang, L., Zhang, Y., Yu, X., & Zhang, L. (2021). Hybrid artificial cell-mediated epigenetic inhibition in metastatic lung cancer. Journal of Colloid and Interface Science, 603, 319–332. https:// doi.org/10.1016/j.jcis.2021.06.066
[13] Rao, S. D., Banack, S. A., Cox, P. A., & Weiss, J. H. (2006). BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Experimental Neurology, 201(1), 244–252. https://doi.org/10.1016/j.expneurol.2006.04.017
[14] Santschi, L., Reyes-Harde, M., & Stanton, P. K. (1999). Chemically Induced, Activity-Independent LTD Elicited by Simultaneous Activation of PKG and Inhibition of PKA. Journal of Neurophysiology, 82(3), 1577–1589. https://doi.org/10.1152/ jn.1999.82.3.1577
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
